Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach

被引：0

作者：

Seong-Ho Kong

Yukinori Kurokawa

Jeong-Hwan Yook

Haruhiko Cho

Oh-Kyoung Kwon

Toru Masuzawa

Kyung Hee Lee

Sohei Matsumoto

Young Soo Park

Hiroshi Honda

Seung-Wan Ryu

Takashi Ishikawa

Hye Jin Kang

Kazuhito Nabeshima

Seock-Ah Im

Toshio Shimokawa

Yoon-Koo Kang

Seiichi Hirota

Han-Kwang Yang

Toshirou Nishida

机构：

[1] Seoul National University Hospital,Department of Surgery, Cancer Research Institute

[2] Seoul National University College of Medicine Cancer Research Institute,Department of Gastroenterological Surgery

[3] Osaka University Graduate School of Medicine,Department of Surgery

[4] University of Ulsan College of Medicine Asan Medical Center,Department of Surgery

[5] Kanagawa Cancer Center,Department of Surgery

[6] Kyungpook National University School of Medicine,Department of Surgery

[7] Kyungpook National University Chilgok Hospital,Department of Hemato

[8] Osaka Police Hospital,Oncology

[9] Yeungnam University College of Medicine,Department of Surgery

[10] Nara Medical University,Department of Pathology

[11] University of Ulsan College of Medicine Asan Medical Center,Department of Surgery

[12] Sendai Open Hospital,Department of Surgery

[13] Keimyung University Dongsan Hospital,Department of Surgery

[14] Niigata University Graduate School of Medical and Dental Sciences,Department of Internal Medicine, Korea Institute of Radiological & Medical Sciences

[15] Korea Cancer Center Hospital,Department of Surgery

[16] Tokai University,Department of Internal Medicine

[17] Seoul National University Hospital and Seoul National University College of Medicine Cancer Research Institute,Clinical Study Support Center

[18] Wakayama Medical University Hospital,Department of Oncology

[19] University of Ulsan College of Medicine Asan Medical Center,Department of Surgical Pathology

[20] Hyogo Medical University School of Medicine,Department of Surgery

[21] Japan Community Health Care Organization Osaka Hospital,undefined

来源：

Gastric Cancer | 2023年 / 26卷

关键词：

Gastrointestinal stromal tumor; Imatinib mesylate; Neoadjuvant; Stomach neoplasm;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：775 / 787

页数：12

共 125 条

[21]

Kang YK(2015)Long-term surgical outcome of 1057 gastric GISTs according to 7th UICC/AJCC TNM system: multicenter observational study from Korea and Japan Med (Baltimore) 94 e1526-138

[22]

Nishida T(2022)Early experience of laparoscopic resection and comparison with open surgery for gastric gastrointestinal stromal tumor: a multicenter retrospective study Sci Rep 12 2290-undefined

[23]

von Mehren M(2014)Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study J Surg Oncol 109 67-undefined

[24]

Fletcher CD(2021)Preservation of organ function in locally advanced non-metastatic gastrointestinal stromal tumors (GIST) of the stomach by neoadjuvant imatinib therapy Cancers (Basel) 273 128-undefined

[25]

Berman JJ(2021)Outcome of 1000 patients with gastrointestinal stromal tumor (GIST) treated by surgery in the pre- and post-imatinib eras Ann Surg undefined undefined-undefined

[26]

Corless C(undefined)undefined undefined undefined undefined-undefined

[27]

Gorstein F(undefined)undefined undefined undefined undefined-undefined

[28]

Lasota J(undefined)undefined undefined undefined undefined-undefined

[29]

Longley BJ(undefined)undefined undefined undefined undefined-undefined

[30]

Miettinen M(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 4 5 6 7 8 9 10 →